Andlauer Healthcare Group (TSE:AND – Get Free Report) had its price target decreased by research analysts at Stifel Nicolaus from C$55.00 to C$52.00 in a research note issued to investors on Monday, BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus’ target price would suggest a potential upside of 28.14% from the stock’s previous close.
Other analysts have also issued research reports about the company. Eight Capital cut their price objective on Andlauer Healthcare Group from C$62.00 to C$58.00 and set a “buy” rating on the stock in a research report on Thursday, March 7th. Royal Bank of Canada reduced their price target on Andlauer Healthcare Group from C$43.00 to C$41.00 and set a “sector perform” rating on the stock in a research report on Monday. CIBC boosted their price objective on Andlauer Healthcare Group from C$50.00 to C$52.00 and gave the stock an “outperform” rating in a research report on Thursday, March 7th. Scotiabank raised their target price on shares of Andlauer Healthcare Group from C$45.00 to C$47.50 and gave the company a “sector perform” rating in a report on Thursday, March 7th. Finally, National Bankshares boosted their price target on shares of Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the stock a “sector perform” rating in a report on Thursday, March 7th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Andlauer Healthcare Group has an average rating of “Moderate Buy” and a consensus price target of C$49.43.
View Our Latest Stock Report on Andlauer Healthcare Group
Andlauer Healthcare Group Stock Performance
Andlauer Healthcare Group (TSE:AND – Get Free Report) last announced its quarterly earnings data on Tuesday, March 5th. The company reported C$0.44 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.49 by C($0.05). The business had revenue of C$169.07 million during the quarter, compared to analyst estimates of C$165.00 million. Andlauer Healthcare Group had a net margin of 10.21% and a return on equity of 14.53%. As a group, analysts anticipate that Andlauer Healthcare Group will post 1.8439434 EPS for the current year.
Andlauer Healthcare Group Company Profile
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Further Reading
- Five stocks we like better than Andlauer Healthcare Group
- Options Trading – Understanding Strike Price
- Garmin Navigates to New Highs Driven By Wearables Trend
- What Makes a Stock a Good Dividend Stock?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- 3 Healthcare Dividend Stocks to Buy
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.